PREDICTORS OF MANUFACTURING (MFG) SUCCESS FOR CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS IN NON-HODGKIN LYMPHOMA

被引：0
|
作者：
Davis, M. M. [1 ,2 ]
Fesnak, A. [1 ,2 ]
Leskowitz, R. M. [1 ,2 ]
McKee, J. S. [1 ,2 ]
Ohayon, Y. [1 ,2 ]
Corl, C. M. [1 ,2 ]
Malykhin, A. [1 ,2 ]
Fraietta, J. A. [1 ,2 ]
Melenhorst, J. Joseph [1 ,2 ]
June, C. [1 ,2 ]
Schuster, S. [3 ]
Levine, B. L. [1 ,2 ]
机构：
[1] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA
[2] Univ Penn, Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA
来源：
CYTOTHERAPY | 2017年 / 19卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
180
引用
收藏
页码：S79 / S80
页数：2
相关论文
共 50 条
  • [1] The Use of Chimeric Antigen Receptor T Cells in Patients With Non-Hodgkin Lymphoma
    Lulla, Premal D.
    Hill, LaQuisa C.
    Ramos, Carlos A.
    Heslop, Helen E.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (05) : 375 - 386
  • [2] Chimeric antigen receptor T cell therapy for non-Hodgkin lymphoma
    Ghobadi, Armin
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2018, 66 (02) : 43 - 49
  • [3] Allogeneic Stem Cell Transplantation and Chimeric Antigen Receptor (CAR) T-Cell Therapy for the Treatment of Non-Hodgkin Lymphoma
    Hunter, Bradley D.
    Chen, Yi-Bin
    Jacobson, Caron A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 33 (04) : 687 - +
  • [4] Chimeric Antigen Receptor T-Cell Therapy in the Management of Relapsed Non-Hodgkin Lymphoma
    Komanduri, Krishna V.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (05) : 476 - +
  • [5] Evaluation of CD70 Chimeric Antigen Receptor T (CAR-T) Cells As a Potential Treatment for Non-Hodgkin's Lymphoma: A Preclinical Study
    Jiang, Pengfei
    Xiong, Qinghui
    Yuan, Xiujie
    Zhang, Haoyu
    Shen, Qiushuang
    Wang, Yang
    Gong, Yiwei
    BLOOD, 2023, 142
  • [6] Early response data for pediatric patients with Non-Hodgkin lymphoma treated with CD19 chimeric antigen receptor (CAR) T-cells
    Rivers, Julie
    Annesley, Colleen
    Summers, Corinne
    Finney, Olivia
    Pulsipher, Michael
    Wayne, Alan
    Park, Julie
    Jensen, Michael
    Gardner, Rebecca
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 23 - 24
  • [7] Early Response Data for Pediatric Patients with Non-Hodgkin Lymphoma Treated with CD19 Chimeric Antigen Receptor (CAR) T-Cells
    Rivers, Julie
    Annesley, Colleen
    Summers, Corinne
    Finney, Olivia
    Pulsipher, Michael A.
    Wayne, Alan S.
    Park, Julie R.
    Jensen, Michael C.
    Gardner, Rebecca
    BLOOD, 2018, 132
  • [8] Role of FDG-PET/CT in patients with Non-Hodgkin Lymphoma treated with Chimeric Antigen Receptor T Cells
    Bailly, C.
    Tessoulin, B.
    Eugene, T.
    Gastinne, T.
    Kraeber-Bodere, F.
    Le Gouill, S.
    Bodet-Milin, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S39 - S39
  • [9] CD30-Chimeric Antigen Receptor (CAR) T Cells for Therapy of Hodgkin Lymphoma (HL)
    Ramos, Carlos A.
    Bilgi, Mrinalini
    Gerken, Claudia
    Dakhova, Olga
    Mei, Zhuyong
    Wu, Men-Feng
    Grilley, Bambi
    Gee, Adrian P.
    Rooney, Cliona M.
    Dotti, Gianpietro
    Savoldo, Barbara
    Heslop, Helen E.
    Brenner, Malcolm K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [10] CD30-Chimeric Antigen Receptor (CAR) T Cells for Therapy of Hodgkin Lymphoma (HL)
    Ramos, Carlos A.
    Bilgi, Mrinalini
    Gerken, Claudia P.
    Dakhova, Olga
    Mei, Zhuyong
    Grilley, Bambi J.
    Gee, Adrian P.
    Rooney, Cliona M.
    Dotti, Gianpietro
    Savoldo, Barbara
    Heslop, Helen E.
    Brenner, Malcolm K.
    BLOOD, 2018, 132
12345